Explore our certified analytical platforms, pre-clinical animal models, in vitro bioassays, and phytochemical screening systems engineered for worldwide regulatory compliance.
Combining verified chromatography infrastructure, GMP pilot lines, and deep multi-center pharmacology partnerships across major industrial corridors.
A rigorous examination of high-performance liquid chromatography, botanical variation modeling, and industrial CDMO synthesis for global brands.
In global botanical therapeutics, nutraceutical manufacturing, and phytopharmaceutical development, analytical imprecision has historically compromised international market entry. Traditional extraction protocols often evaluate raw materials solely by bulk dry weight or non-specific UV absorbance. However, natural phyto-compounds—encompassing bioactive alkaloids, complex polysaccharides, polyphenols, and terpene glycosides—exhibit steep qualitative variability based on soil microbiome composition, seasonal precipitation, elevation, and post-harvest drying dynamics. An ODM HPLC lab functions as the technological cornerstone that bridges empirical botany with quantifiable, reproducible pharmacokinetics.
MedGence (Yineng Pharma), established in Changsha, Hunan, operates at the cross-section of modern chromatographic engineering and pharmacognosy. By pairing high-performance liquid chromatography (HPLC) equipped with Diode Array Detectors (DAD/PDA), Evaporative Light Scattering Detectors (ELSD), and triple-quadrupole Mass Spectrometry (LC-MS/MS) with High-Performance Thin-Layer Chromatography (HPTLC), our laboratory establishes multi-analyte chromatographic fingerprints. This methodology ensures that every batch manufactured for OEM/ODM global deployment achieves rigorous chemical identity verification, stoichiometric consistency, and strict limits on secondary degradation products.
China commands the world's most comprehensive botanical supply chain, direct botanical sourcing ecosystems, and specialized extraction infrastructure. Our facility bridges immediate geo-botanical origin tracking with state-of-the-art analytical instrumentation, offering 40-60% development cost efficiencies compared to Western CROs without sacrificing USP, Ph. Eur., or ChP compliance.
The botanical CDMO industry is transitioning from single-marker testing to multi-component chromatographic fingerprinting and AI-assisted retention-time alignment. Modern regulatory bodies now require holistic metabolomic profiling to prevent adulteration and ensure consistent therapeutic efficacy across international harvest variations.
Enterprise procurement directors require guaranteed batch-to-batch repeatability, transparent audit trails, and strict IP non-disclosure agreements. Entrusting lab testing and scale-up CDMO to a unified partner eliminates the sample distortion and regulatory communication friction common when using disparate vendors.
From botanical drug filings to functional clean-label nutraceuticals and targeted cosmetic dermocosmetics.
We deliver comprehensive ICH-compliant validation dossiers, GLP-grade toxicology profiles, stability chambers testing under accelerated zones, and clinical trial batch production for global botanical drug applications.
Standardize bulk extracts to verifiable biomarker thresholds. Prevent common supply-chain fraud issues (such as synthetic spiking or botanical substitution) via robust HPLC-DAD verification, ensuring clean-label verification.
Isolate unstable phyto-actives with precision temperature control and column chromatography. Our formulations retain peak cellular anti-aging, soothing, and barrier-repair capabilities supported by cellular in vitro models.
Leveraging 56 hospital preparation registrations, we transition proprietary clinical formulas into commercially viable, industrialized formats with complete master batch records and analytical assay protocols.
Eliminate batch discrepancies caused by seasonal variations. Our testing maps regional harvest windows to quantify when target botanical markers peak, minimizing manufacturing waste and raw material costs.
In-depth responses detailing validation criteria, IP safety, equipment configurations, and contract CDMO turnaround times.
Seamlessly scale from benchtop chromatographic assays to commercial production batches with guaranteed quality standard compliance.
